Clinical Trial Update: Eficacy of Long-term Suplementation With Docosahexaenoic Acid in Patients With Cystic Fibrosis [NA]

View source ↗

Summary

This clinical trial update reports on the efficacy of long-term docosahexaenoic acid supplementation in patients with cystic fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Docosahexaenoic acid (docosahexaenoic acid)

Snippet

Sponsor: Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | Conditions: Cystic Fibrosis | NA | Status: COMPLETED